We are live on
!
Find out more
CAM
ClariVest Asset Management Portfolio holdings
AUM
$980M
1-Year Est. Return
60.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.34%
1 Year Est. Return
+60.89%
3 Year Est. Return
+106.43%
5 Year Est. Return
+337.88%
10 Year Est. Return
+1,091.18%
AUM
$1.84B
AUM Growth
-$155M
(-7.8%)
Cap. Flow
-$103M
Cap. Flow
% of AUM
-5.59%
Top 10 Holdings %
Top 10 Hldgs %
39.94%
Holding
870
New
213
Increased
171
Reduced
234
Closed
56
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$16.9M |
| 2 |
Meta Platforms (Facebook)
META
|
+$13.7M |
| 3 |
Eli Lilly
LLY
|
+$13.3M |
| 4 |
Pultegroup
PHM
|
+$8.88M |
| 5 |
Owens Corning
OC
|
+$7.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$16.5M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$12.8M |
| 3 |
Apple
AAPL
|
+$12.4M |
| 4 |
Microsoft
MSFT
|
+$11.7M |
| 5 |
NVIDIA
NVDA
|
+$11.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.68% |
| 2 | Healthcare | 14.34% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Communication Services | 9.89% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
eHealth
EHTH
$43.9M
| $699K | 0.04% |
94,466
| – | – |
|
302
Shift4
FOUR
$3.26B
| $698K | 0.04% |
12,609
| – | – |
|
303
Halozyme
HALO
$12.2B
| $698K | 0.04% |
18,281
| – | – |
|
304
ADMA Biologics
ADMA
$2.22B
| $695K | 0.04% |
194,178
-256
| -0.1% | -$985 |
|
305
Acadia Pharmaceuticals
ACAD
$5.03B
| $694K | 0.04% |
+33,304
| New | +$905K |
|
306
Helmerich & Payne
HP
$3.71B
| $692K | 0.04% |
16,403
| – | – |
|
307
QCR Holdings
QCRH
$1.7B
| $692K | 0.04% |
14,274
-36
| -0.3% | -$1.78K |
|
308
Health Catalyst
HCAT
$128M
| $691K | 0.04% |
68,241
| – | – |
|
309
Dr. Reddy's Laboratories
RDY
$10.2B
| $690K | 0.04% |
51,555
+51,500
| +93,636% | +$697K |
|
|
CWBC
310
Community West Bancshares
CWBC
$684M
| $673K | 0.04% |
47,763
-53
| -0.1% | -$813 |
|
|
CTLP
311
DELISTED
Cantaloupe
CTLP
| $667K | 0.04% |
106,611
| – | – |
|
312
Information Services Group
III
$251M
| $667K | 0.04% |
152,136
| – | – |
|
313
Precigen
PGEN
$2.59B
| $662K | 0.04% |
466,144
-658
| -0.1% | -$933 |
|
314
Conduent
CNDT
$264M
| $645K | 0.04% |
185,305
-299
| -0.2% | -$998 |
|
315
Orion Group Holdings
ORN
$418M
| $640K | 0.03% |
+119,400
| New | +$473K |
|
|
PWSC
316
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $640K | 0.03% |
28,220
-192
| -0.7% | -$4.21K |
|
317
MiMedx Group
MDXG
$633M
| $636K | 0.03% |
87,202
-19,226
| -18% | -$143K |
|
318
TG Therapeutics
TGTX
$7.62B
| $631K | 0.03% |
75,473
+14,140
| +23% | +$197K |
|
319
Commercial Metals
CMC
$8.31B
| $624K | 0.03% |
12,617
-13,224
| -51% | -$719K |
|
320
Harvard Bioscience
HBIO
$29.2M
| $623K | 0.03% |
14,489
-5,384
| -27% | -$248K |
|
321
Distribution Solutions Group
DSGR
$1.61B
| $617K | 0.03% |
23,740
| – | – |
|
322
Ultralife
ULBI
$106M
| $616K | 0.03% |
+63,100
| New | +$506K |
|
323
Tidewater
TDW
$4.12B
| $615K | 0.03% |
+8,661
| New | +$547K |
|
324
Enviri
NVRI
$620M
| $613K | 0.03% |
84,900
+28,100
| +49% | +$227K |
|
|
CMRC
325
Commerce.com Inc Series 1
CMRC
$184M
| $590K | 0.03% |
+59,800
| New | +$623K |
|
Similar funds
GCAC
D
PP
FTIS
AIA
SEC
AFG
ECM
ClariVest Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, ClariVest Asset Management held 870 positions worth $1.84B, down 7.8% from $1.99B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
ClariVest Asset Management withdrew a net $103M in Q3 2023, closing 56 positions and reducing 234 holdings. Its most notable exit was SS&C Technologies, an estimated $11.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, ClariVest Asset Management opened a new position in Owens Corning worth $6.96M.
- ClariVest Asset Management's largest Q3 2023 buy was Owens Corning: 51,032 shares worth $6.96M.
- ClariVest Asset Management added most to TJX Companies in Q3 2023, an estimated $16.9M increase.
- ClariVest Asset Management's biggest Q3 2023 reduction was Merck, cutting an estimated $16.5M.
- ClariVest Asset Management fully exited SS&C Technologies in Q3 2023, selling an estimated $11.2M.
- ClariVest Asset Management's ten largest holdings make up 40% of its $1.84B portfolio in Q3 2023.
- ClariVest Asset Management opened 213 new positions and closed 56 in Q3 2023.
- ClariVest Asset Management's portfolio value fell 7.8% quarter-over-quarter to $1.84B.
Based on ClariVest Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.